These are the results of a new international trial presented at the “Osteoarthritis, Arthritis and Healthy Aging” symposium held at Aragon’s CIBA.The combination of chondroitin sulfate and glucosamine reduces significantly pain and improves joint mobility.Osteoarthritis is the most prevalent rheumatic disease in Aragon, with 16 percent of the population suffering from this condition.
Like last year, Bioibericas Palafolls factory held a technical seminar in November on the use of its Terra-Sorb products in Eastern Europe.
This is the most important conclusion drawn from the post-hoc analysis of the MOVES clinical trial which was presented today at the annual meeting of the American Academy of Rheumatology.
This certification is a recognition of the excellence standards achieved by Bioiberica in their effort to improve energy efficiencyDuring the next three years, our company has set the following objectives: 15% reduction in energy consumption per production unit, 10% of the energy will come from by-product use, and 5% from renewable energies